That’s the whole adult population so includes teachers. I agree that I felt those groups ought to have been prioritised but I can understand the point that to separate groups depending on their occupation would not have been straightforward and would have made the vaccine roll-out as a whole slower. It is a lot easier to just go down by age group, getting jabs into as many people as possible as quickly as possible.
Who knows, maybe when we all need jabbing again towards next winter they might be able to come up with a system where these occupations can be prioritised much like the healthcare workers have been?
But where are you getting that from? Briefed by the German government? On what evidence? The newspaper’s word?
You still aren’t getting it. The EU has advised its nations that Pfizer doses are to be administered 3 weeks apart. The only efficacy figures that should ever be shown in public are its efficacy after a second dose, as that’s the only real-world scenario that the vaccine is ever going to see in these nations. Under no circumstances should its efficacy at 28-34 days after 1 dose be used in a comparison. What next? You are going to tell me a MotoGP superbike is faster than an F1 car on 2 wheels?
So why the hell wouldn’t BBC show those figures instead?? With 96% effectiveness vs Pfizer’s 95% effectiveness it paints them in a positive light. Oh, I know why…
…And you continue to peddle this idea that EU countries as a whole have been critical of AZ’s efficacy when all of the criticism has come from one government: Macron’s. I can’t imagine the likes of yourself and the thousands like you spreading false information is helping public confidence.
Wow, there’s only one person spreading false information between us and it’s not me. Maybe start reading all of the information that’s been published - I’ve put plenty of it here in this thread…stuff that you have acknowledged previously you simply don’t bother to read. It would certainly help inform you a little better and may even stop you from throwing out bullshit smears like you just have. Probably not but I can hope.
Just not true. The EU is advising administering Pfizer doses within 6 weeks. See this table:
From this article:
It is then up to the individual member state’s to set the timelimit within that and some have gone with the recommended optimum of 3-4 weeks. France, notably, has already officially gone to 6 weeks.
Rebutting your false claims is getting rather tedious to be honest.
not sure if this one has already been posted on this thread but It’s scary to see Johnston’s ‘save Christmas’ as it was ‘inhumane’ to stay locked down translated to a graph of the resulting data
Yep, particularly as the government knew by then that there was the new more virulent UK strain in circulation (which will account for some of the difference but makes it even more senseless to have had any relaxation over Christmas).
Seriously dude. You are the greatest bluffer this board is likely ever going to see. Type something and then link articles that contradict what you were saying in the hope that no-one bothers to read🤣.
EMA. Three week interval. You set them up. I’ll continue to knock your bullshit down.
Fuck me. I specifically cited the recommended period but the EMA has stated that the interval should be no more than 6 weeks, which France has already adopted.
It makes a comparison of efficacy between Pfizer and AstraZeneca at 4-6 weeks entirely legitimate.
Last week, reports began to emerge that only a small fraction of the doses of the Oxford/AstraZeneca vaccine distributed to EU member states were being used. For instance, the Timesreported that only 400 of 3,800 daily appointments at Berlin’s Tegel airport, recently closed to flights and repurposed as a vaccination centre, were being filled. Naturally, as I want the jab, I went to Tegel to try my luck.
If only a tenth of daily appointments were really being filled, I reasoned, surely they would have no problem giving spare doses to people who turn up towards the end of the day. After all, successful vaccine programmes such as Israel’s and Britain’s sometimes give out leftover doses to avoid waste.
Unfortunately, my ambition to get immunised came up against German Beamtenmentalität, or bureaucratic mentality. Bored-looking security guards outside Tegel – of which I saw more over roughly half an hour than patients arriving – told my companion and I in no uncertain terms that we would not be getting a vaccine.
Tegel is not an isolated case in Germany. The German health ministry said last week that it had used just 15 per cent of the AstraZeneca doses it has received as people across the country refuse the jab. In Saxony, the German Red Cross told the news programme ZDF Heute that only 20 to 30 appointments were being booked for AstraZeneca jabs daily in the state.
Across Europe, a similar story is playing out. France had issued just 16 per cent of its AstraZeneca doses as of 25 February, Italy a fifth and Spain a third. By contrast, uptake of the Pfizer jab hovers around 80 per cent, according to data from the European Centre for Disease Prevention and Control, an EU agency.
Part of the problem is that many European countries, including Germany and France, have chosen to restrict the use of the vaccine to under-65s because of a lack of clinical trial data on its effectiveness among the elderly, although the EU’s European Medicines Agency has approved the jab for all age groups. Some German officials are now calling for the national regulator to update its guidance and approve the vaccine for all age groups.
Keeping parallel lists of people to invite for an injection may have complicated the logistical task of administration. But possibly equally significant have been weeks of misleading headlines and comments from political leaders.
First, a widely reported story in Germany’s leading financial daily, the Handelsblatt, suggested that the AstraZeneca vaccine was semi-useless among the elderly. Although later shown to be misleading, the story had the effect of entrenching the idea that AstraZeneca was clearly a second-class vaccine to be avoided. This may have partly led to, for instance, the head of a German police union claiming that police officers should get the “best possible vaccine” – in other words, not AstraZeneca, which police have reportedly been refusing. The German chancellor, Angela Merkel, has since attempted to counter vaccine hesitancy among her compatriots, telling citizens: “this is a safe and highly effective vaccine”.
The French president, Emmanuel Macron, subsequently cast aspersions on the effectiveness of the vaccine, infamously claiming last month that “the real problem on AstraZeneca is that it doesn’t work the way we were expecting it to… everything points to thinking it is quasi-ineffective on people older than 65, some say those 60 years or older”. He has now changed his tune, latterly claiming that he would take the vaccine if offered to him.
AstraZeneca would not, on its own, solve the EU’s shambolic vaccine roll-out, in which the bloc has administered 7 doses per 100 people, compared to 23 in the US and 31 in the UK, according to figures collated by Our World in Data, a project at Oxford University. But in the wake of a raucous dispute between the UK and EU after Brussels demanded that AstraZeneca divert supply from the UK to uphold its commitments to the bloc, it is difficult not to see a bleak irony in weeks of misinformation resulting in European citizens not taking the jab.
Meanwhile, staff at Tegel administered only 400 doses a day on the day I visited.
As if this is not complicated enough, I want to throw a spanner in the discussion. What if some of the EU countries start approving the 2 China vaccines now, Sinovac and Sinopharm and the governments say, please take it, would the stance of ‘taking vaccines regardless of brand or source’ still remain the same for you guys? I know Serbia is not technically in the EU but it is the first European nation already vaccinating its citizens with China vaccines, so wondering would the others follow suit?
Ok so there are more nations now then I previously read. If even bigger nations like Germany or France or UK approved it, would you all take it? Or would they even consider it?
